Concepedia

Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial

Farzaneh Dastan, Seyed Alireza Nadji, Ali Saffaei, Majid Marjani, Afshin Moniri, Hamidreza Jamaati, Seyed MohammadReza Hashemian, Parvaneh Baghaei, Atefeh Abedini, Mohammad Varahram,

International Immunopharmacology · 2020 · 80 citations · 12 references

DOIFull text

Open access

Concepts

References

12

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

Zunyou Wu, Jennifer M. McGoogan · JAMA · 2020 · 18K citations · Full text

, , +13

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Victor M. Corman, Olfert Landt, Marco Kaiser et al. · Eurosurveillance · 2020 · 8.2K citations · Full text

, , +17

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Daniel Blanco-Melo, Benjamin E. Nilsson-Payant, Wen‐Chun Liu et al. · Cell · 2020 · 4.5K citations · Full text

, , +12

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Jérôme Hadjadj, Nader Yatim, Laura Barnabei et al. · Science · 2020 · 3.2K citations · Full text

, , +17

Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study

Jaffar A. Al‐Tawfiq, Hisham Momattin, Jean G. Dib et al. · International Journal of Infectious Diseases · 2014 · 329 citations · Full text

, , +17